CDH1 and neoplasm: The proportion of E-cadherin loss was higher in tumours located in the cardia, 57%, when compared to those that were non-cardia in location, 29%, but the difference was not statistically significant [OR 3.2; 95% CI 0.4–27, p=0.21].